Sivers Semiconductors: The $1.2 Billion Bet That Investors Are Struggling to Price

Sivers Semiconductors' Q2 sales fell 12%, EBITDA loss widened, but $1.2B pipeline and 2027 ramp plans fuel analyst optimism.

The arithmetic of transformation rarely looks pretty on a quarterly earnings statement, and Sivers Semiconductors is living proof. The Swedish chipmaker's stock has shed 27 percent over the past seven trading sessions, closing at 2.44 euros after a 15 percent single-day slide on Friday following its second-quarter report. The shares now sit roughly 38 percent below their 50-day moving average of 3.94 euros — a stark reminder of how far the stock has retreated from the spring's explosive rally.

Yet buried beneath the red ink is a counter-narrative that analysts at Redeye have dubbed "A Deliberate Trade-off Ahead of the 2027 Ramp." The research house frames the current pain as a strategic choice: Sivers is deliberately shifting away from development-driven revenue toward a product-led model, accepting near-term deterioration to position itself for a production surge expected in 2027.

The Cost of Ambition

The second-quarter numbers make the trade-off concrete. Net sales fell to 53.8 million Swedish kronor, down 12 percent year-over-year (10 percent on a currency-adjusted basis). The adjusted EBITDA loss widened to 35.5 million kronor from 20.9 million in the year-ago period. Net loss reached 115.0 million kronor, or minus 0.38 kronor per share, while operating cash flow bled 70.0 million kronor.

A significant chunk of the damage stems from a non-cash charge: a 42.9 million kronor social security provision tied to employee stock programs, triggered by the share price's dramatic ascent from 10.71 to 63.15 kronor during the quarter. Swedish business daily Dagens Industri was unsparing in its assessment, branding the report "disastrous" and advising investors to steer clear.

The Pipeline That Could Change Everything

Set against the operational weakness is an order pipeline that has swollen to $1.2 billion as of July — a 268 percent increase since the end of 2025. Product revenue climbed 18 percent on a currency-adjusted basis. The company has been steadily broadening its customer base: a collaboration with SemiNex announced roughly two weeks ago, production orders from Allspace, and additional production orders from a LiDAR customer described as imminent.

The company is also placing a fresh bet on the AI infrastructure boom, having launched a development program for next-generation indium phosphide light sources targeting optical interconnects for AI-focused data centers. Technical specifications and timelines remain undisclosed, but the strategic direction is clear: position Sivers in a segment attracting heavy global investment.

Capital, Conversion, and Questions

To fund the planned production ramp, Sivers raised 825 million kronor in gross equity roughly two weeks ago and converted a $12 million convertible loan into equity. That conversion came from lender Bootstrap Europe, which exercised its conversion rights in July and pulled all remaining warrants in August.

But Bootstrap Europe's involvement has raised governance questions. Media reports citing analysts at Affärsvärlden suggest the lender may have sold a substantial portion of its stake without the mandatory disclosure required upon crossing the 5 percent reporting threshold. The short-seller community has also stirred: Arrowstreet Capital and Citadel Securities have emerged as new disclosed short positions, while D. E. Shaw has exited its position entirely. The annualized 30-day volatility stands at a striking 169 percent.

A Transatlantic Horizon

Management's answer to the skepticism is a planned dual listing on the Nasdaq in New York, with preparations targeted for completion in the first half of 2027. The move aims to boost international visibility and open access to US capital markets.

The stock's technical picture offers little comfort: the RSI of 37.2 points to moderate weakness rather than oversold conditions, suggesting the selling pressure may not be exhausted. Over the past 30 days, however, the shares have managed a modest 2.3 percent gain — a reminder that the recent slide follows an extraordinary run-up.

Whether Redeye's thesis holds will ultimately depend on whether the $1.2 billion pipeline converts into tangible revenue when the promised 2027 ramp arrives. For now, investors are being asked to look past a deteriorating income statement, a dilutive capital raise, and unresolved questions about insider selling — and trust that the deliberate trade-off pays off.